Endovascular and surgical treatment of cerebral venous thrombosis

Created 09/04/2021, last revision 29/09/2023

  • patients with extensive thrombosis may benefit from recanalization treatment:
    • if no improvement is observed with anticoagulation treatment
    • in patients with rapidly deteriorating consciousness due to extensive thrombosis and/or involvement of the deep venous system
  • endovascular therapy aims to re-establish anterograde venous outflow in the targeted sinus and alleviate malignant venous congestion
  • recanalization (whether complete or partial) is associated with an improved outcome compared to those without recanalization
  • however, the randomized TO-ACT trial did not demonstrate a significant benefit of interventional therapy over standard medical therapy

Intravenous thrombolysis

  • intravenous thrombolysis (IVT) is rarely used; treatment results are inconclusive, and IVT seems to increase the risk of bleeding
  • dosage is not standardized (and is not discussed in recent guidelines)
    • according to small studies, a continuous infusion of ALTEPLASE 1-2 mg/h is used
    • the duration of thrombolysis is unclear ⇒ 24-48 h may be considered
  • insufficient data exist to recommend this treatment, particularly in patients expected to have a favorable prognosis (ESO guidelines 2017)

Local thrombolysis / mechanical recanalization

  • intra-sinus therapy should be performed in centers with expertise in endovascular treatment
  • advisable in extensive venous thromboses where no significant effect of anticoagulation can be expected and in cases with progressive clinical deterioration
  • always consider decompressive craniectomy
  • ESO guidelines 2017 do not address endovascular treatment (nor its indication or technical implementation)

Local (intra-sinus) thrombolysis (LIST)

  • randomized trials are lacking, but the efficacy of endovascular therapy is supported by case series
    • analysis of several cohorts of 235 patients [Llyas, 2017]
    • a review encompassed 185 patients undergoing mechanical recanalization, achieving partial or complete recanalization in 95% of cases (AngioJet was used in 40% of cases) [Siddiqui, 2015]
  • the presence of ischemic and/or hemorrhagic lesions is not a contraindication to LIST
  • retrograde access, mostly via the femoral vein, is used; a microcatheter is inserted into the affected sinus for continuous infusion
  • patients are heparinized throughout the procedure
  • different dosing regimens  exist (total dose 8-300mg, median dose 78.4±64.7mg, median therapy duration 41±49h)  [Canhao, 2003]

ALTEPLASE (Actilyse / Activase)

  • bolus  2-10 mg into the thrombus, then continuous infusion of 1-2 mg/h  [Lee, 2018]
  • bolus 10 mg into the thrombus, followed by 15 mg/h for 3 hours and then 5 mg/h (max 100mg/day) [Kim, 1997]
  • usually given for 24-48 h (max. 200 mg in total)


  • 200-1000 IU/h administered together with tPA serves to flush the catheter and prevent pulmonary embolism
  • repeat angiography every 12-24 hours to monitor response to local thrombolysis
  • thrombolysis may be combined with thrombectomy (see below)
  • continue standard anticoagulant therapy after completion of the procedure

Mechanical thrombectomy

  • thrombolysis can be combined with mechanical methods such as thrombus disruption, thrombectomy, or angioplasty
  • thrombectomy can also be performed as a standalone primary procedure, notably in cases with extensive bleeding [Lee, 2018]
  • several devices are used:
Successful recanalization of the transverse sinus with the Penumbra catheter. Sagittal sinus remained obstructed despite repeated attempts
Recanalization of the transverse sinus was achieved by thrombectomy with the Penumbra device.
Endovascular treatment modalities in cerebral venous thrombosis [Lee, 2018]


External ventricular drainage (EVD)

  • consider in patients with developing obstructive hydrocephalus; however, data are insufficient to make a formal recommendation (ESO guidelines 2017)
  • consider carefully – surgery requires temporary interruption of anticoagulant/thrombolytic therapy

Decompressive craniectomy

  • decompressive craniectomy, with/without hematoma evacuation, is typically reserved for patients with large parenchymal lesions causing herniation
  • a life-saving procedure that increases the chance of a favorable outcome even in the most severe CVT cases (ESO guidelines 2017)
    • better results can be expected in non-comatose, young patients with unilateral lesions
  • there are no data to guide the choice between hemicraniectomy and endovascular or when and how to combine them
Decompressive craniectomy in CVT

Optic nerve decompression

  • indicated for substantial papilledema and imminent blindness
  • optic nerve sheath fenestration (ONSF) alleviates intraneural pressure and facilitates venous outflow
  • the procedure requires interruption of anticoagulation/thrombolytic therapy
  • intervention may result in visual improvement and resolution of papilledema [Murdock, 2014]

You cannot copy content of this page

Send this to a friend
you may find this topic useful:

Endovascular and surgical treatment of cerebral venous thrombosis
link: https://www.stroke-manual.com/cerebral-venous-thrombosis-endovascular-treatment-surgery/